




To the Editor: Lyme disease is the
most frequent tickborne human infec-
tion in the northern hemisphere. At
least 5 species of the Borrelia
burgdorferi sensu lato complex, B.
burgdorferi sensu stricto, B. afzelii, B.
garinii, B. bissettii, and B. lusitaniae,
have a pathogenic role in human
Lyme disease in central Europe (1–3).
A sixth pathogenic strain, A14S, has
been isolated from 1 Dutch (4) and 2
German patients with erythema
migrans (5). This strain was also
detected in 4 questing Ixodes ricinus
ticks in Germany (6,7) and 1 in the
Czech Republic (8). A14S has recent-
ly been described as a new species, B.
spielmanii (9); its main reservoir host
is probably the garden dormouse
(Eliomys quercinus), but B. spielmanii
could not be detected in mice or voles.
Richter et al. (9) could not find ticks
harboring  B. spielmanii in 3 of 5
examined areas in Germany. They
were present almost exclusively in a
single area where the prevalence of
infection with this genotype was 15
(6%) of 251. We describe the isolation
of this novel Lyme disease spirochete
from a human patient with erythema
migrans in Hungary.
Since 1999, we have regularly iso-
lated Borrelia burgdorferi sensu lato
from skin biopsy specimens of erythe-
ma migrans and acrodermatitis chron-
ica atrophicans taken from patients at
the Center for Tick-borne Diseases,
Budapest, Hungary. To identify the
Borrelia species occurring in
Hungarian Lyme disease patients, we
have started to molecularly analyze
cultured isolates that originate from
erythema migrans of different
patients. DNA was isolated from 8
bacterial pellets by using QIAamp
DNA mini kit (Qiagen, Hilden,
Germany). Primers BSL-F and BSL-
R were used; these amplify an ≈250-
bp region of the outer surface protein
(osp) A gene from all Lyme disease
spirochetes (10). We added 2 µL
extracted DNA to a 20-µL reaction
mixture composed of 1.0 U HotStart-
Taq DNA polymerase, 200 µmol/L of
each dNTP, 25 pmol of each primer,
and 1.5 mmol/L MgCl2 (HotStartTaq
Master Mix, Qiagen). An initial
denaturation step at 94°C for 15 min
was followed by 40 cycles of denatu-
ration at 94°C for 30 s, annealing at
58°C for 30 s, and extension at 72°C
for 30 s. Final extension was done at
72°C for 5 min. Amplified DNA was
subjected to electrophoresis in a 1.5%
agarose gel that was prestained with
ethidium bromide and viewed under
UV light. After purification, the
dideoxy chain termination (Applied
Biosystems Division, Foster City, CA,
USA) was used for sequencing.
Obtained sequences were checked
with Chromas v.1.45 and compared to
sequence data available from
GenBank by using BLAST (http://
www.ncbi.nlm.nih.gov/BLAST/).
New sequences were submitted to
GenBank.
Six sequences (DQ007298, DQ00-
7299, DQ007300, DQ007301, DQ00-
7302, DQ007303) showed 100%
homology to B. afzelii Khab 625
strain (AY502599). One (DQ007297)
of the remaining 2 samples showed
99.6% similarity with B. burgdorferi
B31 (AE000790), and the other
(AY995900) showed 99.21% similar-
ity with B. spielmanii (AF102057).
The patient whose culture showed
B. spielmanii was a 42-year-old
woman with a homogenous erythema
migrans, diagnosed on September 24,
1999. The erythema was 10 cm in
diameter on the front surface of the
knee at the first visit (see online
Figure, available at http://www.
cdc.gov/ncidod/EID/vol11no11/05-
0542-G.htm). The immunoglobulin M
(IgM) and IgG Borrelia immunoblot
that applied B. afzelii (ACA1) antigen
was negative in serum drawn on the
seventh day after the appearance of
erythema migrans. The patient did not
remember a tick bite and had not trav-
eled abroad during the previous 6
months. She complained of an
“extremely unusual,” intense, serous
nasal discharge that started 3 weeks
before the appearance of erythema
migrans and of a moderate headache;
both disappeared spontaneously 2
weeks before treatment.
Our results show at least 3 distinct
species of B. burgdorferi sensu lato in
Hungary. In addition to B. burgdorferi
sensu stricto and B. afzelii, known
throughout Europe, we detected the
recently described species B. spiel-
manii among randomly selected sam-
ples. Together with 2 previous publi-
cations (4,5), our observation also
suggest that B. spielmanii has a path-
ogenic role in human Lyme disease.
Although B. spielmanii is distributed
more focally than other species of the
B. burgdorferi sensu lato complex (9),
it occurs from the Netherlands
through Germany and Czech
Republic to Hungary (4,5,7,8).
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To the Editor: Mycobacterium
ulcerans is an emerging human
pathogen responsible for Buruli ulcer,
a necrotizing skin disease most com-
monly found in West Africa, but out-
breaks have also been reported in the
Americas, Australia, and Asia (1).
Environmental sources of infection
and mode of transmission are not
completely known. M. ulcerans
grows slowly at 32°C, requiring 6–8
weeks for colonies to be visible in pri-
mary culture. Differentiation from M.
marinum, which also causes skin
infections, is important, since M. mar-
inum can usually be treated with
antimicrobial agents, whereas M.
ulcerans most often does not respond
favorably to drug therapy, and treat-
ment is usually by surgical excision
(2). M. shinshuense, initially isolated
from a child in Japan, is phenotypical-
ly and genetically related but bio-
chemically distinct from M. ulcerans
(3). 
In the last decade, several DNA-
based techniques for mycobacterial
identification have been developed.
Rapid molecular detection and differ-
entiation of organisms that cause skin
infections directly from tissue or exu-
dates could be of great value for early
treatment. Some techniques, especial-
ly those that include nucleic acid
amplification, could be used directly
on clinical samples. The accepted
standard for molecular identification
of mycobacteria is sequencing analy-
sis of 2 hypervariable regions identi-
fied in 16S rRNA gene. M. marinum
and  M. ulcerans share identical 5′-
16S rDNA and 16S-23S rRNA gene
spacer sequences (4). Polymerase
chain reaction (PCR)-dependent
methods are based on the 16S rRNA
gene (5), the hsp65 gene (6) or the
insertion sequence IS2404 (7).
Recently, a novel category of variable
number tandem repeats that could dis-
tinguish M. marinum and M. ulcerans
genotypes has been described (8).
Polymorphisms in the 3′-16S
rDNA region discriminate M. ulcer-
ans from M. marinum and M. shin-
shuense  (5). These polymorphisms
also allow the separation of M. ulcer-
ans into 3 subgroups according to
geographic origin and variable pheno-
typic differences. IS2404 discrimi-
nates M. ulcerans from M. marinum
(7). It has been used in restriction
fragment length polymorphism analy-
sis applied to a comparable number of
M. ulcerans and M. marinum strains,
confirming that this sequence is pres-
ent in high copy numbers in M. ulcer-
ans  but absent in M. marinum.
Nevertheless, an unusual mycobac-
terium was recently isolated that is
closely related to M. marinum by phe-
notypic tests, lipid pattern, and partial
16S rDNA sequencing but presents
low copy numbers of this element (9).
PCR-restriction enzyme analysis
(PRA) of a 441-bp fragment of the
hsp65 gene is a rapid, easy, and inex-
pensive method for identifying
mycobacteria (10). Devallois et al. (6)
described the PRA-hsp65 pattern of 1
M. ulcerans strain ATCC 33728 that
originated in Japan. This isolate was
considered a new species that resem-
bled M. ulcerans and was named M.
shinshuense (3). 
We report here the usefulness of
PRA-hsp65 to differentiate M. ulcer-
ans strains from different geographic
areas. Since Buruli ulcer cases have
been reported on 5 continents, we
studied 33 M. ulcerans strains that
originated from Africa (Benin, Zaire,
Ghana, Congo, Angola, Côte d’Ivoire,
Togo), Asia (China, Malaysia),
Australia (Papua New Guinea,
Australia), the Caribbean (Mexico,
Surinam, French Guiana), 1 M. shin-
shuense from Japan, 1 M. marinum
isolate and 1 IS2404-positive M. mar-
inum isolate from France (9). All
strains were identified at the Institute
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